Prognostic and predictive biomarkers in patients with COVID-19 treated with tocilizumab in a randomised controlled trial
Jennifer Tom, Min Bao, Larry Tsai, Aditi Qamra, David Summers, Montserrat Carrasco-Triguero, Jacqueline McBride, Carrie M Rosenberger, Celia J F Lin, William Stubbings, Kevin G Blyth, Jordi Carratalà, Bruno François, Thomas Benfield, Derrick Haslem, Paolo Bonfanti, Cor H van der Leest, Nidhi Rohatgi, Lothar Wiese, Charles Edouard Luyt, Farrah Kheradmand, Ivan O Rosas, Fang Cai
doi: https://doi.org/10.1101/2020.12.23.20247379
Jennifer Tom
1Genentech, South San Francisco, CA, USA
PhDMin Bao
1Genentech, South San Francisco, CA, USA
MDLarry Tsai
1Genentech, South San Francisco, CA, USA
MDAditi Qamra
2Hoffmann-La Roche Ltd, Mississauga, ON, Canada
PhDDavid Summers
3Roche Products Ltd, Welwyn Garden City, UK
MSMontserrat Carrasco-Triguero
1Genentech, South San Francisco, CA, USA
PhDJacqueline McBride
1Genentech, South San Francisco, CA, USA
PhDCarrie M Rosenberger
1Genentech, South San Francisco, CA, USA
PhDCelia J F Lin
1Genentech, South San Francisco, CA, USA
MDWilliam Stubbings
4F Hoffmann-La Roche Ltd, Basel, Switzerland
PhDKevin G Blyth
5Institute of Cancer Sciences, University of Glasgow/Department of Respiratory Medicine, Queen Elizabeth University Hospital, Glasgow, UK
MDJordi Carratalà
6Department of Infectious Diseases, Bellvitge University Hospital, Bellvitge Biomedical Research Institute, University of Barcelona, and Spanish Network for Research in Infectious Diseases, Barcelona, Spain
MDBruno François
7Intensive Care Unit and INSERM CIC1435 and UMR1092, CHU Limoges, Limoges, France
MDThomas Benfield
8Center of Research and Disruption of Infectious Diseases, Department of Infectious Diseases, Copenhagen University Hospital, Amager Hvidovre, Hvidovre, Denmark
MDDerrick Haslem
9Intermountain Medical Group, St George, UT, USA
MDPaolo Bonfanti
10University of Milano–Bicocca and Azienda Ospedaliera San Gerardo di Monza, Monza, Italy
MDCor H van der Leest
11Amphia Ziekenhuis, Breda, Netherlands
MDNidhi Rohatgi
12Division of Hospital Medicine, Stanford University School of Medicine, Stanford, CA, USA
MDLothar Wiese
13Department of Infectious Diseases Zealand University Hospital, Roskilde, Denmark
MDCharles Edouard Luyt
14Medical Intensive Care Unit and INSERM UMRS 1166-iCAN, Institute of Cardiometabolism and Nutrition, Sorbonne Université, Hopital de la Pitie Salpetriere, Assistance Publique- Hôpitaux de Paris, Paris, France
MDFarrah Kheradmand
15Baylor College of Medicine, Houston, TX, USA
MDIvan O Rosas
15Baylor College of Medicine, Houston, TX, USA
MDFang Cai
1Genentech, South San Francisco, CA, USA
MDData Availability
Qualified researchers may request access to individual patient level data through the clinical study data request platform (https://vivli.org/). Further details on Roche's criteria for eligible studies are available here (https://vivli.org/members/ourmembers/). For further details on Roche's Global Policy on the Sharing of Clinical Information and how to request access to related clinical study documents, see here (https://www.roche.com/research_and_development/who_we_are_how_we_work/clinical_trials/our_commitment_to_data_sharing.htm).
Posted December 26, 2020.
Prognostic and predictive biomarkers in patients with COVID-19 treated with tocilizumab in a randomised controlled trial
Jennifer Tom, Min Bao, Larry Tsai, Aditi Qamra, David Summers, Montserrat Carrasco-Triguero, Jacqueline McBride, Carrie M Rosenberger, Celia J F Lin, William Stubbings, Kevin G Blyth, Jordi Carratalà, Bruno François, Thomas Benfield, Derrick Haslem, Paolo Bonfanti, Cor H van der Leest, Nidhi Rohatgi, Lothar Wiese, Charles Edouard Luyt, Farrah Kheradmand, Ivan O Rosas, Fang Cai
medRxiv 2020.12.23.20247379; doi: https://doi.org/10.1101/2020.12.23.20247379
Prognostic and predictive biomarkers in patients with COVID-19 treated with tocilizumab in a randomised controlled trial
Jennifer Tom, Min Bao, Larry Tsai, Aditi Qamra, David Summers, Montserrat Carrasco-Triguero, Jacqueline McBride, Carrie M Rosenberger, Celia J F Lin, William Stubbings, Kevin G Blyth, Jordi Carratalà, Bruno François, Thomas Benfield, Derrick Haslem, Paolo Bonfanti, Cor H van der Leest, Nidhi Rohatgi, Lothar Wiese, Charles Edouard Luyt, Farrah Kheradmand, Ivan O Rosas, Fang Cai
medRxiv 2020.12.23.20247379; doi: https://doi.org/10.1101/2020.12.23.20247379
Subject Area
Subject Areas
- Addiction Medicine (380)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2823)
- Dermatology (242)
- Emergency Medicine (426)
- Epidemiology (12517)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4397)
- Geriatric Medicine (399)
- Health Economics (712)
- Health Informatics (2831)
- Health Policy (1044)
- Hematology (372)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (113)
- Nephrology (460)
- Neurology (4155)
- Nursing (220)
- Nutrition (614)
- Oncology (2188)
- Ophthalmology (622)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (263)
- Palliative Medicine (81)
- Pathology (484)
- Pediatrics (1166)
- Primary Care Research (481)
- Public and Global Health (6738)
- Radiology and Imaging (1480)
- Respiratory Medicine (896)
- Rheumatology (429)
- Sports Medicine (361)
- Surgery (469)
- Toxicology (57)
- Transplantation (198)
- Urology (173)